Literature DB >> 19520274

Congenital myasthenic syndrome with episodic apnea.

Leah A Mallory1, James G Shaw, Stephanie L Burgess, Elicia Estrella, Samuel Nurko, Tyler M Burpee, Michael S Agus, Basil T Darras, Louis M Kunkel, Peter B Kang.   

Abstract

Congenital myasthenic syndrome is difficult to diagnose, especially in the neonate when classic myasthenic signs may not be present. Congenital myasthenic syndrome with episodic apnea is a rare cause of recurrent apnea in infancy. We present an infant with nine severe episodes of apnea in her first 6 months who underwent a prolonged evaluation before ptosis was evident, leading to a diagnosis of choline acetyltransferase deficiency, a form of congenital myasthenic syndrome. Midazolam appeared to resolve the apnea on five occasions. The diagnosis was supported by edrophonium testing and repetitive nerve stimulation. Mutation analysis demonstrated compound heterozygous p.T354M and p.A557T mutations, the latter of which is novel. The patient's respiratory status stabilized on pyridostigmine, and she is ambulatory at age 3 years. Pyridostigmine is the primary therapy for choline acetyltransferase deficiency, but the efficacy of midazolam during this patient's episodes of apnea is interesting, and warrants further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520274      PMCID: PMC2718786          DOI: 10.1016/j.pediatrneurol.2009.02.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

Review 1.  Causes of apparent life threatening events in infants: a systematic review.

Authors:  M C McGovern; M B H Smith
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

2.  Differences between midazolam and propofol sedation on upper airway collapsibility using dynamic negative airway pressure.

Authors:  J Russell Norton; Denham S Ward; Suzanne Karan; William A Voter; Linda Palmer; Anna Varlese; Ori Rackovsky; Peter Bailey
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

3.  Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Authors:  Kinji Ohno; Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Joan Brengman; C Michel Harper; Akira Tsujino; Margherita Milone
Journal:  Am J Hum Genet       Date:  2002-01-14       Impact factor: 11.025

4.  The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability.

Authors:  Ni Ni Win; Haruhisa Fukayama; Hikaru Kohase; Masahiro Umino
Journal:  Anesth Analg       Date:  2005-07       Impact factor: 5.108

5.  Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants.

Authors:  N Barisic; J S Müller; E Paucic-Kirincic; M Gazdik; K Lah-Tomulic; A Pertl; J Sertic; N Zurak; H Lochmüller; A Abicht
Journal:  Eur J Paediatr Neurol       Date:  2004-12-13       Impact factor: 3.140

6.  Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

Authors:  K Ohno; A Tsujino; J M Brengman; C M Harper; Z Bajzer; B Udd; R Beyring; S Robb; F J Kirkham; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Authors:  Akira Tsujino; Chantal Maertens; Kinji Ohno; Xin-Ming Shen; Taku Fukuda; C Michael Harper; Stephen C Cannon; Andrew G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

8.  Congenital myasthenic syndrome associated with episodic apnea and sudden infant death.

Authors:  R F Byring; H Pihko; A Tsujino; X-M Shen; B Gustafsson; P Hackman; K Ohno; A G Engel; B Udd
Journal:  Neuromuscul Disord       Date:  2002-08       Impact factor: 4.296

  8 in total
  9 in total

Review 1.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 2.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

3.  Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Authors:  Xin-Ming Shen; Thomas O Crawford; Joan Brengman; Gyula Acsadi; Susan Iannaconne; Emin Karaca; Chaouky Khoury; Jean K Mah; Shimon Edvardson; Zeljko Bajzer; David Rodgers; Andrew G Engel
Journal:  Hum Mutat       Date:  2011-09-23       Impact factor: 4.878

4.  Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.

Authors:  Juan Arredondo; Marian Lara; Sídney M Gospe; Claudio G Mazia; Maria Vaccarezza; Marcela Garcia-Erro; Constance M Bowe; Celia H Chang; Michelle M Mezei; Ricardo A Maselli
Journal:  Hum Mutat       Date:  2015-07-24       Impact factor: 4.878

5.  Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.

Authors:  Trevor M Morey; Warren Winick-Ng; Claudia Seah; R Jane Rylett
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

6.  Novel mutations in SLC6A5 with benign course in hyperekplexia.

Authors:  Hormos Salimi Dafsari; Amit Kawalia; Rosanne Sprute; Mert Karakaya; Anna Malenica; Peter Herkenrath; Peter Nürnberg; Susanne Motameny; Holger Thiele; Sebahattin Cirak
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13

7.  Mutation of a serine near the catalytic site of the choline acetyltransferase a gene almost completely abolishes motility of the zebrafish embryo.

Authors:  Swarnima Joshi; Sanamjeet Virdi; Christelle Etard; Robert Geisler; Uwe Strähle
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

8.  Congenital Myasthenic Syndrome Caused by a Novel Hemizygous CHAT Mutation.

Authors:  Yixia Zhang; Xinru Cheng; Chenghan Luo; Mengyuan Lei; Fengxia Mao; Zanyang Shi; Wenjun Cao; Jingdi Zhang; Qian Zhang
Journal:  Front Pediatr       Date:  2020-04-28       Impact factor: 3.418

9.  Genetic test for Mendelian fatigue and muscle weakness syndromes.

Authors:  Aysha Karim Kiani; Bruno Amato; Silvia Maitz; Savina Nodari; Sabrina Benedetti; Francesca Agostini; Lorenzo Lorusso; Enrica Capelli; Astrit Dautaj; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.